Stem Cell Differentiation Stage Factors and their Role in Triggering Symmetry Breaking Processes during Cancer Development: A Quantum Field Theory Model for Reprogramming Cancer Cells to Healthy Phenotypes
-
Published:2019-05-13
Issue:6
Volume:26
Page:988-1001
-
ISSN:0929-8673
-
Container-title:Current Medicinal Chemistry
-
language:en
-
Short-container-title:CMC
Author:
Biava P.M.1, Burigana F.2, Germano R.3, Kurian P.4, Verzegnassi C.5, Vitiello G.6
Affiliation:
1. Scientific Institute of Research and Care Multimedica, Via Milanese 300 Sesto S. G., Milano, Italy 2. Associazione Medicina e Complessita, Trieste, Italy 3. PROMETE_CNR Spin off, Piazzale V. Tecchio, 45, Napoli, Italy 4. Quantum Biology Laboratory, Howard University, Washington, DC, United States 5. Politecnico di Ingegneria e Architettura, Universita di Udine, Udine, Italy and Associazione Medicina e Complessita, Trieste, Italy 6. Dipartimento di Fisica , Italy
Abstract
A long history of research has pursued the use of embryonic factors isolated during cell differentiation processes for the express purpose of transforming cancer cells back to healthy phenotypes. Recent results have clarified that the substances present at different stages of cell differentiation—which we call stem cell differentiation stage factors (SCDSFs)—are proteins with low molecular weight and nucleic acids that regulate genomic expression. The present review summarizes how these substances, taken at different stages of cellular maturation, are able to retard proliferation of many human tumor cell lines and thereby reprogram cancer cells to healthy phenotypes. The model presented here is a quantum field theory (QFT) model in which SCDSFs are able to trigger symmetry breaking processes during cancer development. These symmetry breaking processes, which lie at the root of many phenomena in elementary particle physics and condensed matter physics, govern the phase transitions of totipotent cells to higher degrees of diversity and order, resulting in cell differentiation. In cancers, which share many genomic and metabolic similarities with embryonic stem cells, stimulated redifferentiation often signifies the phenotypic reversion back to health and nonproliferation. In addition to acting on key components of the cellular cycle, SCDSFs are able to reprogram cancer cells by delicately influencing the cancer microenvironment, modulating the electrochemistry and thus the collective electrodynamic behaviors between dipole networks in biomacromolecules and the interstitial water field. Coherent effects in biological water, which are derived from a dissipative QFT framework, may offer new diagnostic and therapeutic targets at a systemic level, before tumor instantiation occurs in specific tissues or organs. Thus, by including the environment as an essential component of our model, we may push the prevailing paradigm of mutation-driven oncogenesis toward a closer description of reality.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference96 articles.
1. Biava PM, Canaider S, Facchin F, Bianconi E, Ljungberg L, Rotilio D, Burigana F, Ventura C. Curr Pharm Biotechnol, Stem cell differentiation stage factors from zebrafish embryo: A novel strategy to modulate the fate of normal and pathological human (stem) cells.,, 2015, 16,, 782-792, 2. Biava PM, Bonsignorio D, Hoxa M. J Tumor Marker Oncol, Life-protecting factor (LPF): An anti-cancer low molecular weight fraction isolated from pregnant uterine mucosa during embryo organogenesis.,, 2000, 15,, 223-233, 3. Livraghi T, Meloni F, Frosi A, Lazzaroni S, Bizzarri TM, Frati L, Biava PM. Oncol Res, Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial.,, 2005, 15,, 399-408, 4. Livraghi T, Ceriani R, Palmisano A, Pedicini V, Pich MG, Tommasini MA, Torzilli G. Curr Pharm Biotechnol, Complete response in 5 out of 38 patients with advanced hepatocellular carcinoma treated with stem cell differentiation stage factors: case reports from a single centre.,, 2011, 12,, 254-260, 5. Biava PM, Bonsignorio D. J Tumor Marker Oncol, Cancer and cell differentiation: a model to explain malignancy.,, 2002, 17,, 47-54,
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|